Opto™ Assure Aggregation Assay
As therapeutic molecules become more complex, developing cell lines that make high yield, high-quality product has become more challenging. Opto Assure makes earlier assessment of product quality possible, so you get the best cells and a faster, lower-risk path to volume production – even for complex molecules like bispecifics.
This first assay in the Opto Assure line enables direct detection of product aggregates within days of single cell cloning. With this assay, you can confidently identify and select clones that secrete high-quality complex molecules and minimize risk during downstream scale up.
How to get to market faster with Opto cell line development
In this datasheet from Berkeley Lights, discover how to get to market faster with Opto™ cell line development.
Bring product quality assessment into early clone selection with the Opto Assure Aggregation Assay
In this application note, Berkeley Lights introduces the Opto™ Assure Aggregation assay, which enables detection of product aggregates within days of single cell cloning.
5 top technology stories and latest industry developments in cell line development
Gain insights from industry experts, access free downloads, webinars, and more to streamline your cell line development







